Zebrafish as a Model Organism Market
Zebrafish as a Model Organism Market Scope:
Industry Analysis, Market Size, Growth, Trends Till
2031
Request Sample Report
Zebrafish as a Model Organism Market Size and Growth
The zebrafish as a model organism market is experiencing significant growth, driven by advancements in genetic research and drug discovery. Valued at approximately $175 million in 2023, the market is projected to expand at a CAGR of over 7% due to increasing demand from both academic and pharmaceutical sectors. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Shanghai Model Organisms Center
◍ Inc.
◍ ZeClinics
◍ InVivo Biosystems
◍ Biobide
◍ Pentagrit
◍ Evotec
◍ Aurigene Pharmaceutical Services
◍ Ikan Biotech
◍ Bioreperia
◍ Hangzhou Hunter Biotechnology Co.
◍ Ltd.
◍ YSY BIOTECH
◍ Eze-Rinka
◍ INVENesis
◍ FEIFAN TEST
◍ Charles River Laboratories
The Zebrafish as a Model Organism Market includes companies like Shanghai Model Organisms Center and Charles River Laboratories, which utilize zebrafish for drug discovery, toxicology, and genetic studies. Their contributions enhance research capabilities and market growth. Sales revenue specifics include Charles River at approximately $3 billion. Other figures are typically confidential.
Request Sample Report
Market Segmentation
By Application
By Product
Others ◍ Pharmaceutical
Biotechnology ◍ Chemical ◍ Cosmetics ◍ Water Quality Monitoring ◍ Others
◍ Toxicity Testing Services
◍ Transgenesis and Gene Editing Services
◍ Disease Models
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
